Do adult disease severity subclassifications predict use of cyclophosphamide in children with ANCA-associated vasculitis? An analysis of ARChiVe study treatment decisions

Kimberly Morishita, Jaime Guzman, Peter Chira, Eyal Muscal, Andrew Zeft, Marisa Klein-Gitelman, America G. Uribe, Leslie Abramson, Susanne M. Benseler, Anne Eberhard, Kaleo Ede, Philip J. Hashkes, Aimee O. Hersh, Gloria Higgins, Lisa F. Imundo, Lawrence Jung, Susan Kim, Daniel J. Kingsbury, Erica F. Lawson, Tzielan LeeSuzanne C. Li, Daniel J. Lovell, Thomas Mason, Deborah McCurdy, Kathleen M. O'Neil, Marilynn Punaro, Suzanne E. Ramsey, Andreas Reiff, Margalit Rosenkranz, Kenneth N. Schikler, Rosie Scuccimarri, Nora G. Singer, Anne M. Stevens, Heather Van Mater, Dawn M. Wahezi, Andrew J. White, David A. Cabral

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint Dive into the research topics of 'Do adult disease severity subclassifications predict use of cyclophosphamide in children with ANCA-associated vasculitis? An analysis of ARChiVe study treatment decisions'. Together they form a unique fingerprint.

Medicine & Life Sciences